Inventor

Ann Haren

Ann Haren
I invented a method to analyze concave polymer surfaces using FTIR
I invented a production process to crystallize insulinotropin protein in-situ in order to develop a product that would have slow deliverability to type two diabetics. The process was sold by Pfizer to Novo Nordisk in 1994.